Results 11 to 20 of about 9,492,801 (363)

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

open access: yesNew England Journal of Medicine, 2020
Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection,
B. Cao   +64 more
semanticscholar   +1 more source

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

open access: yesNew England Journal of Medicine, 2020
Background World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19 ...
H. Pan   +73 more
semanticscholar   +1 more source

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers.
H. D. de Koning   +23 more
semanticscholar   +1 more source

Trial of Psilocybin versus Escitalopram for Depression.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking.
R. Carhart-Harris   +9 more
semanticscholar   +1 more source

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Nonalcoholic steatohepatitis (NASH) is a common disease that is associated with increased morbidity and mortality, but treatment options are limited.
P. Newsome   +8 more
semanticscholar   +1 more source

Prototype of running clinical trials in an untrustworthy environment using blockchain. [PDF]

open access: yes, 2019
Monitoring and ensuring the integrity of data within the clinical trial process is currently not always feasible with the current research system.
Bhattacharya, Sanchita   +2 more
core   +3 more sources

For the benefit of others: reasons why women with breast cancer participate in RCTs [PDF]

open access: yes, 2015
Introduction: Appreciation of the barriers and drivers affecting enrolment in randomised clinical trials (RCTs) is important for future trial design, communication and information provision.
Fallowfield, Lesley, Jenkins, Valerie
core   +1 more source

Soundscape Optimization in Nursing Homes Through Raising Awareness in Nursing Staff With MoSART+

open access: yesFrontiers in Psychology, 2022
IntroductionSoundscapes in nursing homes are often suboptimal for residents. This can cause them feeling anxious and unsafe, or develop behavioral and psychological problems.
Janouk Kosters   +6 more
doaj   +1 more source

Understanding controlled trials: Crossover trials

open access: yesBMJ, 1998
This is the fifth of an occasional series on the methods of randomised controlled trials In a crossover trial subjects are randomly allocated to study arms where each arm consists of a sequence of two or more treatments given consecutively. The simplest model is the AB/BA study.
Sibbald, Bonnie, Roberts, Chris
openaire   +4 more sources

« Mon quartier a changé un peu, mais c’est moi qui ai aussi beaucoup changé ». Habiter la ville et y vieillir

open access: yesMétropoles, 2019
Ageing in urban environments is a growing challenge for Western societies. Unfortunately, the issue remains under-addressed in the field of social sciences and little is known about it.
Loïc Riom   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy